NDC 72162-2296

NDC codes

FDA NDC Directory

Product NDC (as listed)72162-2296Labeler and product segments. Claims need a package NDC.

Product NDC at billing width72162-2296Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
72162-2296-2	72162229602	1 BOTTLE, PUMP in 1 CARTON (72162-2296-2) / 45 g in 1 BOTTLE, PUMPMarketed from Apr 30, 2024

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%
Generic name (nonproprietary): adapalene and benzoyl peroxide gel, 0.1%/2.5%
Active ingredients: Adapalene — 1 mg/gBenzoyl peroxide — 25 mg/g
Dosage form: Gel
Route: Topical
Labeler: Bryant Ranch Prepack
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 206164
Marketing start: Aug 14, 2023
Listing expires: Dec 31, 2026
Other FDA classes: Retinoids (Chemical structure)
Identifiers: Product ID 72162-2296_7d9cddd2-9ba1-472a-a4c9-02290fa450a1SPL ID 7d9cddd2-9ba1-472a-a4c9-02290fa450a1SPL set ID 049ea4d9-c60e-4406-b199-da5abe92ecedRxCUI 829539UNII 1L4806J2QF, W9WZN9A0GM
Pharmacologic class: Retinoid

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N472162229602 followed by a unit qualifier and the quantity

Package 72162-2296-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2025.

Indications (excerpt from the label)

Adapalene and benzoyl peroxide gel 0.1% / 2.5% is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. Adapalene and benzoyl peroxide gel 0.1% / 2.5% is a combination of adapalene, a retinoid, and benzoyl peroxide, and is indicated for the topical treatment of acne vulgaris in patients 9 years of age and older. (1)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 206164

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 206164
Product	Strength	Form · route	Labeler	Product NDC
Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5%	Adapalene 1 mg/g; Benzoyl peroxide 25 mg/g	GelTopical	Encube Ethicals, Inc.	21922-052

Adapalene and Benzoyl Peroxide Gel, 0.1%/2.5% NDC 72162-2296